- This event has passed.
The Role of the Nigerian Health System in the Prevention of Female Genital Mutilation/Cutting
February 5 @ 10:00 am - 11:00 am
Organized by ICRW
The Role of the Nigerian Health System in the
Prevention of Female Genital Mutilation/Cutting
Wednesday, February 5, 2020
10:00 AM – 11:00 AM
For those who would like to join ICRW at the ICRW office to view the livestream, please RSVP by clicking here.
Join ICRW for their next Insight to Action event, as they host the second 2019 Paula Kantor Award winner and Program Officer, Grantmaking and International Partnerships at the International Women’s Health Coalition (IWHC), Otibho Obianwu, as she discusses the Nigerian health system’s role in the prevention of FGM/C.
Female genital mutilation/cutting remains widespread in Nigeria, with a national prevalence of 18.4 percent among women ages 15 to 49 years and 25.3 percent among girls younger than 15. With a population of over 190 million people, this translates into millions of women and girls that have been cut. The health system offers a unique platform to facilitate both FGM/C abandonment and care for women and girls who have suffered complications.
Dr. Obianwu will be sharing findings from a mixed-methods study that sought to examine how the Nigerian health system supports the prevention of FGM/C, determine the health system’s role in the management of FGM/C-related complications, assess the quality of care offered to clients and identify possible solutions for strengthening the health system’s capacity to manage and prevent FGM/C.
More About Dr. Obianwu
Otibho Obianwu is currently a Program Officer, Grantmaking and International Partnerships at the International Women’s Health Coalition (IWHC) where she identifies, resources, and supports feminist women and youth-led organizations advancing the sexual and reproductive health and rights of women and adolescent girls globally. Before joining IWHC she worked at the Population Council – Nigeria where she oversaw key research studies as part of the Evidence to End FGM/C consortium, a multi-country research program on female genital/cutting (FGM/C).
Prior to her work on FGM/C, Otibho contributed to research, program, and advocacy efforts to understand, elevate, and address some of the challenges facing key populations at risk for HIV infection. She also led evidence-based advocacy efforts to ensure governmental and civil society organizations addressed the sexual and reproductive health vulnerabilities of Nigerian adolescents and young people in their policies and programs. Additionally, she volunteered as part of the founding leadership at the Women’s Health and Equal Rights Initiative, a feminist nonprofit organization focused on advancing the rights, health, and well-being of lesbian, bisexual, and queer (LBQ) women in Nigeria. Otibho holds an MD from Columbia University Vagelos College of Physicians and Surgeons and an MPH from the Harvard T.H. Chan School of Public Health.